Therefore, Galectin-3 seems to be a pivotal molecule triggering neurodegenerative, oxidative and inflammatory processes preceding vascular modifications in diabetic retinopathy, and its modulation might be a useful tool to prevent diabetic visual complications. The gene discussed is LGALS3; the disease is diabetic retinopathy.